DEPT OF DEFENSE | DEFENSE HEALTH AGENCY (DHA) has floated a tender for Blood Sample Testing. The project location is USA and the tender is closing on 03 Mar 2025. The tender notice number is , while the TOT Ref Number is 115517142. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : USA

Summary : Blood Sample Testing

Deadline : 03 Mar 2025

Other Information

Notice Type : Tender

TOT Ref.No.: 115517142

Document Ref. No. :

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Description

The Defense Health Agency Contracting Activity Healthcare Contracting Division- Southeast intends to negotiate on a sole source basis (FAR 13.106-1(b)(1)), soliciting from a single source. The proposed source is Creative Testing Solutions (Cage Code: 5ZNQ0), 2424 W Erie Dr., Tempe AZ 85282-3113.

The Defense Health Agency Contracting Activity Healthcare Contracting Division- Southeast has a requirement for transportation, packaging supplies, and testing for the Blood Donor Center at Naval Medical Center Camp Lejeune (NMCCL). The transportation, packaging supplies, and testing services are for Blood Donor Panel (HIV-1/2, HTLV-I/II, HBsAg, HCV, HBc, HIV/HCV/HBV NAT (Pool), WNV (Pool), ABO/Rh, AB Screen, Syphilis, CMV)), T. Cruzi (Chagas), Antibody Titers, HLA 1-2, Babesia, and West Nile virus. The blood testing services, collect blood samples, and results must be within 24 hours of a pick-up request.

There are not set-aside restrictions for this requirement. The intended procurement will be classified under North America Industry Classification System (NAICS) 621511. This notice of intent is not a request for competitive proposals and no solicitation document exists for this requirement. However, parties interested in responding to this notice will need to submit technical data sufficient to determine capability in providing the same product. All capability statements received by the closing date of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.

If a vendor challenges the basis of this requirement, please email product capability statements (formats for submission: PDF, MS Word, or MS Excel) to Mrs. Gerrie Johnson at Gerrie.m.johnson.civ@health.mil . Closing date for challenges is no...
Active Contract Opportunity
Notice ID :
Related Notice : 12172529
Department/Ind. Agency : DEPT OF DEFENSE
Sub-tier : DEFENSE HEALTH AGENCY (DHA)
Office: DEFENSE HEALTH AGENCY
General Information
Contract Opportunity Type: Special Notice (Original)
Original Published Date: Feb 27, 2025 05:25 pm EST
Original Response Date: Mar 03, 2025 08:00 am EST
Inactive Policy: 15 days after response date
Original Inactive Date: Mar 18, 2025
Initiative: None

Classification
Original Set Aside:
Product Service Code: Q508 - HEMATOLOGY & ONCOLOGY
NAICS Code: 621511 - Medical Laboratories

Place of Performance: Camp Lejeune, NC 28547 USA

Documents

 Tender Notice


Procurement Documents for USA

Access a comprehensive library of standard procurement documents specific to USA. Here, you'll find all the essential forms, guidelines, and templates required for tender applications and submissions in USA

Explore Procurement Documents for USA


Want To Bid in This Tender?

Get Local Agent Support in USA and 60 More Countries.

View All The Services


View Tenders By


Publish Tenders


Have Any Dispute With The Purchaser?